The global market for Breast Cancer Screening was estimated to be worth US$ 48 million in 2023 and is forecast to a readjusted size of US$ 85 million by 2030 with a CAGR of 8.4% during the forecast period 2024-2030

Breast Cancer Screening - Market

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Screening, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Breast Cancer Screening by region & country, by Type, and by Application.

The Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Breast Cancer Screening.

Market Segmentation

Scope of Breast Cancer Screening - Market Report

Report Metric	Details
Report Name	Breast Cancer Screening - Market
Forecasted market size in 2030	US$ 85 million
CAGR	8.4%
Forecasted years	2024 - 2030
Segment by Type:	Mammography Screening Breast Magnetic Resonance Imaging (MRI) Screening Breast Ultrasound Screening
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Breast Cancer Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Breast Cancer Screening - Market size in 2030?

Ans: The Breast Cancer Screening - Market size in 2030 will be US$ 85 million.

What is the market share of major companies in Breast Cancer Screening - Market?

Ans: Global top three manufacturers hold a share about 65%.

What is the Breast Cancer Screening - Market share by type?

Ans: In terms of product, Mammography Screening is the largest segment, with a share about 70%.

Who are the main players in the Breast Cancer Screening - Market report?

Ans: The main players in the Breast Cancer Screening - Market are Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device, IMS Srl

What are the Application segmentation covered in the Breast Cancer Screening - Market report?

Ans: The Applications covered in the Breast Cancer Screening - Market report are Hospital, Clinic

What are the Type segmentation covered in the Breast Cancer Screening - Market report?

Ans: The Types covered in the Breast Cancer Screening - Market report are Mammography Screening, Breast Magnetic Resonance Imaging (MRI) Screening, Breast Ultrasound Screening

1 Market Overview

1.1 Breast Cancer Screening Product Introduction

1.2 Global Breast Cancer Screening Market Size Forecast

1.2.1 Global Breast Cancer Screening Sales Value (2019-2030)

1.2.2 Global Breast Cancer Screening Sales Volume (2019-2030)

1.2.3 Global Breast Cancer Screening Sales Price (2019-2030)

1.3 Breast Cancer Screening Market Trends & Drivers

1.3.1 Breast Cancer Screening Industry Trends

1.3.2 Breast Cancer Screening Market Drivers & Opportunity

1.3.3 Breast Cancer Screening Market Challenges

1.3.4 Breast Cancer Screening Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Breast Cancer Screening Players Revenue Ranking (2023)

2.2 Global Breast Cancer Screening Revenue by Company (2019-2024)

2.3 Global Breast Cancer Screening Players Sales Volume Ranking (2023)

2.4 Global Breast Cancer Screening Sales Volume by Company Players (2019-2024)

2.5 Global Breast Cancer Screening Average Price by Company (2019-2024)

2.6 Key Manufacturers Breast Cancer Screening Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Breast Cancer Screening Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Breast Cancer Screening

2.9 Breast Cancer Screening Market Competitive Analysis

2.9.1 Breast Cancer Screening Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Breast Cancer Screening Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Mammography Screening

3.1.2 Breast Magnetic Resonance Imaging (MRI) Screening

3.1.3 Breast Ultrasound Screening

3.2 Global Breast Cancer Screening Sales Value by Type

3.2.1 Global Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Breast Cancer Screening Sales Value, by Type (2019-2030)

3.2.3 Global Breast Cancer Screening Sales Value, by Type (%) (2019-2030)

3.3 Global Breast Cancer Screening Sales Volume by Type

3.3.1 Global Breast Cancer Screening Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Breast Cancer Screening Sales Volume, by Type (2019-2030)

3.3.3 Global Breast Cancer Screening Sales Volume, by Type (%) (2019-2030)

3.4 Global Breast Cancer Screening Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.2 Global Breast Cancer Screening Sales Value by Application

4.2.1 Global Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Breast Cancer Screening Sales Value, by Application (2019-2030)

4.2.3 Global Breast Cancer Screening Sales Value, by Application (%) (2019-2030)

4.3 Global Breast Cancer Screening Sales Volume by Application

4.3.1 Global Breast Cancer Screening Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Breast Cancer Screening Sales Volume, by Application (2019-2030)

4.3.3 Global Breast Cancer Screening Sales Volume, by Application (%) (2019-2030)

4.4 Global Breast Cancer Screening Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Breast Cancer Screening Sales Value by Region

5.1.1 Global Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Breast Cancer Screening Sales Value by Region (2019-2024)

5.1.3 Global Breast Cancer Screening Sales Value by Region (2025-2030)

5.1.4 Global Breast Cancer Screening Sales Value by Region (%), (2019-2030)

5.2 Global Breast Cancer Screening Sales Volume by Region

5.2.1 Global Breast Cancer Screening Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Breast Cancer Screening Sales Volume by Region (2019-2024)

5.2.3 Global Breast Cancer Screening Sales Volume by Region (2025-2030)

5.2.4 Global Breast Cancer Screening Sales Volume by Region (%), (2019-2030)

5.3 Global Breast Cancer Screening Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Breast Cancer Screening Sales Value, 2019-2030

5.4.2 North America Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Breast Cancer Screening Sales Value, 2019-2030

5.5.2 Europe Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Breast Cancer Screening Sales Value, 2019-2030

5.6.2 Asia Pacific Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Breast Cancer Screening Sales Value, 2019-2030

5.7.2 South America Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Breast Cancer Screening Sales Value, 2019-2030

5.8.2 Middle East & Africa Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Breast Cancer Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Breast Cancer Screening Sales Value

6.2.1 Key Countries/Regions Breast Cancer Screening Sales Value, 2019-2030

6.2.2 Key Countries/Regions Breast Cancer Screening Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Breast Cancer Screening Sales Value, 2019-2030

6.3.2 United States Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Breast Cancer Screening Sales Value, 2019-2030

6.4.2 Europe Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Breast Cancer Screening Sales Value, 2019-2030

6.5.2 China Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.5.3 China Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Breast Cancer Screening Sales Value, 2019-2030

6.6.2 Japan Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Breast Cancer Screening Sales Value, 2019-2030

6.7.2 South Korea Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Breast Cancer Screening Sales Value, 2019-2030

6.8.2 Southeast Asia Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Breast Cancer Screening Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Breast Cancer Screening Sales Value, 2019-2030

6.9.2 India Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

6.9.3 India Breast Cancer Screening Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Hologic

7.1.1 Hologic Company Information

7.1.2 Hologic Introduction and Business Overview

7.1.3 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Hologic Breast Cancer Screening Product Offerings

7.1.5 Hologic Recent Development

7.2 GE Healthcare

7.2.1 GE Healthcare Company Information

7.2.2 GE Healthcare Introduction and Business Overview

7.2.3 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.2.4 GE Healthcare Breast Cancer Screening Product Offerings

7.2.5 GE Healthcare Recent Development

7.3 Siemen Healthineers

7.3.1 Siemen Healthineers Company Information

7.3.2 Siemen Healthineers Introduction and Business Overview

7.3.3 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Siemen Healthineers Breast Cancer Screening Product Offerings

7.3.5 Siemen Healthineers Recent Development

7.4 Philips Healthcare

7.4.1 Philips Healthcare Company Information

7.4.2 Philips Healthcare Introduction and Business Overview

7.4.3 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Philips Healthcare Breast Cancer Screening Product Offerings

7.4.5 Philips Healthcare Recent Development

7.5 Canon Medical

7.5.1 Canon Medical Company Information

7.5.2 Canon Medical Introduction and Business Overview

7.5.3 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Canon Medical Breast Cancer Screening Product Offerings

7.5.5 Canon Medical Recent Development

7.6 Fujifilm

7.6.1 Fujifilm Company Information

7.6.2 Fujifilm Introduction and Business Overview

7.6.3 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Fujifilm Breast Cancer Screening Product Offerings

7.6.5 Fujifilm Recent Development

7.7 Metaltronica

7.7.1 Metaltronica Company Information

7.7.2 Metaltronica Introduction and Business Overview

7.7.3 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Metaltronica Breast Cancer Screening Product Offerings

7.7.5 Metaltronica Recent Development

7.8 Sino Medical-Device

7.8.1 Sino Medical-Device Company Information

7.8.2 Sino Medical-Device Introduction and Business Overview

7.8.3 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sino Medical-Device Breast Cancer Screening Product Offerings

7.8.5 Sino Medical-Device Recent Development

7.9 IMS Srl

7.9.1 IMS Srl Company Information

7.9.2 IMS Srl Introduction and Business Overview

7.9.3 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2019-2024)

7.9.4 IMS Srl Breast Cancer Screening Product Offerings

7.9.5 IMS Srl Recent Development

8 Industry Chain Analysis

8.1 Breast Cancer Screening Industrial Chain

8.2 Breast Cancer Screening Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Breast Cancer Screening Sales Model

8.5.2 Sales Channel

8.5.3 Breast Cancer Screening Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Breast Cancer Screening Market Trends

Table 2. Breast Cancer Screening Market Drivers & Opportunity

Table 3. Breast Cancer Screening Market Challenges

Table 4. Breast Cancer Screening Market Restraints

Table 5. Global Breast Cancer Screening Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Breast Cancer Screening Revenue Market Share by Company (2019-2024)

Table 7. Global Breast Cancer Screening Sales Volume by Company (2019-2024) & (Units)

Table 8. Global Breast Cancer Screening Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Breast Cancer Screening Price by Company (2019-2024) & (K USD/Unit)

Table 10. Key Manufacturers Breast Cancer Screening Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Breast Cancer Screening Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Breast Cancer Screening

Table 13. Global Breast Cancer Screening Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Breast Cancer Screening Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Breast Cancer Screening Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Breast Cancer Screening Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Breast Cancer Screening Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Breast Cancer Screening Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Breast Cancer Screening Sales Volume by Type: 2019 VS 2023 VS 2030 (Units)

Table 22. Global Breast Cancer Screening Sales Volume by Type (2019-2024) & (Units)

Table 23. Global Breast Cancer Screening Sales Volume by Type (2025-2030) & (Units)

Table 24. Global Breast Cancer Screening Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Breast Cancer Screening Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Breast Cancer Screening Price by Type (2019-2024) & (K USD/Unit)

Table 27. Global Breast Cancer Screening Price by Type (2025-2030) & (K USD/Unit)

Table 28. Global Breast Cancer Screening Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Breast Cancer Screening Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Breast Cancer Screening Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Breast Cancer Screening Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Breast Cancer Screening Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Breast Cancer Screening Sales Volume by Application: 2019 VS 2023 VS 2030 (Units)

Table 34. Global Breast Cancer Screening Sales Volume by Application (2019-2024) & (Units)

Table 35. Global Breast Cancer Screening Sales Volume by Application (2025-2030) & (Units)

Table 36. Global Breast Cancer Screening Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Breast Cancer Screening Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Breast Cancer Screening Price by Application (2019-2024) & (K USD/Unit)

Table 39. Global Breast Cancer Screening Price by Application (2025-2030) & (K USD/Unit)

Table 40. Global Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Breast Cancer Screening Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Breast Cancer Screening Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Breast Cancer Screening Sales Value by Region (2019-2024) & (%)

Table 44. Global Breast Cancer Screening Sales Value by Region (2025-2030) & (%)

Table 45. Global Breast Cancer Screening Sales Volume by Region (Units): 2019 VS 2023 VS 2030

Table 46. Global Breast Cancer Screening Sales Volume by Region (2019-2024) & (Units)

Table 47. Global Breast Cancer Screening Sales Volume by Region (2025-2030) & (Units)

Table 48. Global Breast Cancer Screening Sales Volume by Region (2019-2024) & (%)

Table 49. Global Breast Cancer Screening Sales Volume by Region (2025-2030) & (%)

Table 50. Global Breast Cancer Screening Average Price by Region (2019-2024) & (K USD/Unit)

Table 51. Global Breast Cancer Screening Average Price by Region (2025-2030) & (K USD/Unit)

Table 52. Key Countries/Regions Breast Cancer Screening Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Breast Cancer Screening Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Breast Cancer Screening Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Breast Cancer Screening Sales Volume, (2019-2024) & (Units)

Table 56. Key Countries/Regions Breast Cancer Screening Sales Volume, (2025-2030) & (Units)

Table 57. Hologic Company Information

Table 58. Hologic Introduction and Business Overview

Table 59. Hologic Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 60. Hologic Breast Cancer Screening Product Offerings

Table 61. Hologic Recent Development

Table 62. GE Healthcare Company Information

Table 63. GE Healthcare Introduction and Business Overview

Table 64. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 65. GE Healthcare Breast Cancer Screening Product Offerings

Table 66. GE Healthcare Recent Development

Table 67. Siemen Healthineers Company Information

Table 68. Siemen Healthineers Introduction and Business Overview

Table 69. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 70. Siemen Healthineers Breast Cancer Screening Product Offerings

Table 71. Siemen Healthineers Recent Development

Table 72. Philips Healthcare Company Information

Table 73. Philips Healthcare Introduction and Business Overview

Table 74. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 75. Philips Healthcare Breast Cancer Screening Product Offerings

Table 76. Philips Healthcare Recent Development

Table 77. Canon Medical Company Information

Table 78. Canon Medical Introduction and Business Overview

Table 79. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 80. Canon Medical Breast Cancer Screening Product Offerings

Table 81. Canon Medical Recent Development

Table 82. Fujifilm Company Information

Table 83. Fujifilm Introduction and Business Overview

Table 84. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 85. Fujifilm Breast Cancer Screening Product Offerings

Table 86. Fujifilm Recent Development

Table 87. Metaltronica Company Information

Table 88. Metaltronica Introduction and Business Overview

Table 89. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 90. Metaltronica Breast Cancer Screening Product Offerings

Table 91. Metaltronica Recent Development

Table 92. Sino Medical-Device Company Information

Table 93. Sino Medical-Device Introduction and Business Overview

Table 94. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 95. Sino Medical-Device Breast Cancer Screening Product Offerings

Table 96. Sino Medical-Device Recent Development

Table 97. IMS Srl Company Information

Table 98. IMS Srl Introduction and Business Overview

Table 99. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2019-2024)

Table 100. IMS Srl Breast Cancer Screening Product Offerings

Table 101. IMS Srl Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Breast Cancer Screening Downstream Customers

Table 105. Breast Cancer Screening Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Breast Cancer Screening Product Picture

Figure 2. Global Breast Cancer Screening Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Breast Cancer Screening Sales Volume (2019-2030) & (Units)

Figure 5. Global Breast Cancer Screening Sales Price (2019-2030) & (K USD/Unit)

Figure 6. Breast Cancer Screening Report Years Considered

Figure 7. Global Breast Cancer Screening Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Breast Cancer Screening Players Sales Volume Ranking (2023) & (Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Breast Cancer Screening Revenue in 2023

Figure 10. Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Mammography Screening Picture

Figure 12. Breast Magnetic Resonance Imaging (MRI) Screening Picture

Figure 13. Breast Ultrasound Screening Picture

Figure 14. Global Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Breast Cancer Screening Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Breast Cancer Screening Sales Volume by Type (2019 VS 2023 VS 2030) & (Units)

Figure 17. Global Breast Cancer Screening Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Breast Cancer Screening Price by Type (2019-2030) & (K USD/Unit)

Figure 19. Product Picture of Hospital

Figure 20. Product Picture of Clinic

Figure 21. Global Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Breast Cancer Screening Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Breast Cancer Screening Sales Volume by Application (2019 VS 2023 VS 2030) & (Units)

Figure 24. Global Breast Cancer Screening Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Breast Cancer Screening Price by Application (2019-2030) & (K USD/Unit)

Figure 26. North America Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Breast Cancer Screening Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Breast Cancer Screening Sales Volume (%), (2019-2030)

Figure 38. United States Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 44. China Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 46. China Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 56. India Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030

Figure 58. India Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030

Figure 59. Breast Cancer Screening Industrial Chain

Figure 60. Breast Cancer Screening Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions